Zenas BioPharma shares rise nearly 8% in market debut-February 2024-www.financetom.com

Zenas BioPharma shares rise nearly 8% in market debut

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Zenas BioPharma shares rise nearly 8% in market debut

Sep 13, 2024 12:19 PM

Sept 13 (Reuters) - Shares of Bristol-Myers

Squibb-backed Zenas BioPharma rose nearly 8% in their

Nasdaq debut on Friday, in a sign of recovery for the U.S. IPO

market in 2024 after two sub par years.

Previous page： Savers Value Village Q4 Adjusted Earnings Drop, Sales Rise -- Shares Slump After Hours Next page： Dynavax Technologies Books Q4 Profit as Revenue Rises

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Savers Value Village Q4 Adjusted Earnings Drop, Sales Rise -- Shares Slump After Hours

Feb 20, 2025

05:20 PM EST, 02/20/2025 (MT Newswires) -- Savers Value Village ( SVV ) reported Q4 adjusted net income late Thursday of $0.10 per diluted share, down from $0.15 a year earlier. Analysts polled by FactSet expected $0.12. Net sales for the quarter ended Dec. 28 were $402.0 million, up from $382.8 million a year earlier. Analysts surveyed by FactSet expected...

Dynavax Technologies Books Q4 Profit as Revenue Rises

Feb 20, 2025

05:18 PM EST, 02/20/2025 (MT Newswires) -- Dynavax Technologies ( DVAX ) reported Q4 diluted earnings late Thursday of $0.05 per share, compared with $0.00 a year earlier. Analysts polled by FactSet expected $0.04. Revenue for the quarter ended Dec. 31 was $72.0 million, up from $55.6 million a year earlier. Analysts surveyed by FactSet expected $72.7 million. ...

Maximus Insider Sold Shares Worth $988,030, According to a Recent SEC Filing

Feb 20, 2025

05:20 PM EST, 02/20/2025 (MT Newswires) -- Ilene R. Baylinson, General Manager, Health & Human, on February 19, 2025, sold 14,500 shares in Maximus ( MMS ) for $988,030. Following the Form 4 filing with the SEC, Baylinson has control over a total of 2,512 common shares of the company, with 2,512 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1032220/000095017025024259/xslF345X05/ownership.xml ...

Spirit Airlines gets court approval for $795 million debt deal

Feb 20, 2025

NEW YORK (Reuters) - A U.S. bankruptcy judge on Thursday approved Spirit Airlines' ( SAVEQ ) debt restructuring, clearing the budget airline to convert $795 million in debt to equity and emerge from bankruptcy as a private company. U.S. Bankruptcy Judge Sean Lane approved the airline's restructuring proposal at a court hearing in White Plains, New York. Spirit's bankruptcy plan...